| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Mosseri Marlio Charles serves as a 10% Owner at NVCT. Across recent SEC filings that breaks down to 38 buys and 0 sells. Those positions are worth an estimated $71.7M at current prices.
Historically, Mosseri Marlio Charles's trades have earned a below-average insider score of 46/100 across 31 rated trades. Over a 12-month horizon, 24.0% of those trades were profitable, with an average 12-month return of -35.9%.
The biggest single holding is NVCT (~$71.7M) as 10% Owner. Net of sales, the recent Form 4 record there shows accumulation of 764,217 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 26, 2023 | NVCT Nuvectis Pharma, Inc. | 10% Owner | Buy | 16,760 | $16.46 | $275,869.60 | +0.7% | -16.6% | -56.8% | |
| Jun 23, 2023 | NVCT Nuvectis Pharma, Inc. | 10% Owner | Buy | 73,175 | $17.43 | $1,275,440.25 | +3.0% | -19.3% | -58.4% | |
| Jun 22, 2023 | NVCT Nuvectis Pharma, Inc. | 10% Owner | Buy | 13,090 | $17.72 | $231,963.88 | +0.3% | -23.0% | -60.2% | |
| Jun 16, 2023 | NVCT Nuvectis Pharma, Inc. | 10% Owner | Buy | 12,700 | $17.75 | $225,425.00 | +0.5% | -22.5% | -62.6% | |
| Jun 15, 2023 | NVCT Nuvectis Pharma, Inc. | 10% Owner | Buy | 32,124 | $17.71 | $568,848.04 | +0.7% | -23.6% | -62.8% |